Rapamycin Induces Remission in Early RA, Pilot Study N=25

Jonas · 2023-12-30T16:59:45.604Z

Rapamycin Induces Remission in Early RA via Treg Upregulation, Enabling Prednisone De-escalation:
A Pilot Study (N25) Annals of Rheumatic Diseases 2018
The dose of rapamycin used in the study was 0.5mg every 2 days for 24 weeks .

Screenshot 2023-12-30 at 9.08.06 AM1350×238 27.4 KB

Annals of the Rheumatic Diseases – 1 Jun 18

AB0376 Rapamycin induces remission in patients with newly diagnosed...

Background Rheumatoid arthritis (RA) is an autoimmune disease characterised by chronic inflammation of the joints. We found that there was an imbalance between Th17 and Treg cells in the patients with active refractory RA, reduced absolute number of...

Screenshot 2023-12-30 at 9.10.20 AM1706×426 63.6 KB